- JP-listed companies
- RIBOMIC Inc.
- Dividends
RIBOMIC Inc.【JP:4591】Dividends
Market cap
¥4.4B
P/E ratio
-3.8x
Ribomics develops next-generation aptamer drugs using its proprietary RiboART System to treat unmet medical needs like achondroplasia and eye diseases.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of RIBOMIC Inc., the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- -
Dividend Policy
<p>The company prioritizes securing funds to support ongoing research and development activities and currently has no plans to pay dividends. In the future, the company will consider dividend distributions while taking into account business performance and financial condition. If dividends are implemented, the basic policy will be to pay dividends once per fiscal year as a year-end dividend. Retained earnings will be allocated to research and development activities and related purposes.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2025/05/13) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2025/05/13) | 0 | 0 | 0 | - |
| Forecast(2024/05/14) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2024/05/14) | 0 | 0 | 0 | - |
| Forecast(2023/05/12) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2023/05/12) | 0 | 0 | 0 | - |
| Forecast(2022/05/13) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2022/05/13) | 0 | 0 | 0 | - |
| Forecast(2021/05/13) | 0 | 0 | 0 | - | |
| FY2021 | Actual(2021/05/13) | 0 | 0 | 0 | - |
| Forecast(2020/11/12) | 0 | 0 | 0 | - | |
| FY2020 | Actual(2020/11/12) | 0 | 0 | 0 | - |